Xeris Biopharma Holdings, Inc. (XERS)
16.97
+0.35
(+2.11%)
USD |
NASDAQ |
Nov 20, 16:00
17.01
+0.04
(+0.24%)
After-Hours: 20:00
Xeris Biopharma Holdings Cash and Short Term Investments (Annual) : 111.04M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 111.04M |
| December 31, 2024 | 71.62M |
| December 31, 2023 | 72.45M |
| December 31, 2022 | 121.97M |
| December 31, 2021 | 102.43M |
| Date | Value |
|---|---|
| December 31, 2020 | 133.79M |
| December 31, 2019 | 75.55M |
| December 31, 2018 | 112.63M |
| December 31, 2017 | 42.04M |
| December 31, 2016 | 32.27M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Ligand Pharmaceuticals, Inc. | 733.52M |
| MBX Biosciences, Inc. | 373.70M |
| ANI Pharmaceuticals, Inc. | 294.75M |
| Corcept Therapeutics, Inc. | 372.15M |
| Veru, Inc. | 18.32M |